115 related articles for article (PubMed ID: 16785868)
1. What is the clinical significance of infusing hematopoietic cell grafts contaminated with bacteria?
Kelly M; Roy DC; Labbe AC; Laverdiere M
Bone Marrow Transplant; 2006 Aug; 38(3):183-8. PubMed ID: 16785868
[TBL] [Abstract][Full Text] [Related]
2. Microbial contamination of hematopoietic stem cell products: incidence and clinical sequelae.
Klein MA; Kadidlo D; McCullough J; McKenna DH; Burns LJ
Biol Blood Marrow Transplant; 2006 Nov; 12(11):1142-9. PubMed ID: 17085307
[TBL] [Abstract][Full Text] [Related]
3. Microbial contamination of hematopoietic progenitor cell grafts-incidence, clinical outcome, and cost-effectiveness: an analysis of 735 grafts.
Kamble R; Pant S; Selby GB; Kharfan-Dabaja MA; Sethi S; Kratochvil K; Kohrt N; Ozer H
Transfusion; 2005 Jun; 45(6):874-8. PubMed ID: 15934984
[TBL] [Abstract][Full Text] [Related]
4. Application of pulsed-field gel electrophoresis to identify the source of bacterial contamination of peripheral blood progenitor cell products.
Reich-Slotky R; Wu F; Della-Latta P; Savage DG; Schwartz J
Transfusion; 2008 Nov; 48(11):2409-13. PubMed ID: 18657076
[TBL] [Abstract][Full Text] [Related]
5. Sterility testing of hematopoietic progenitor cell products: a single-institution series of culture-positive rates and successful infusion of culture-positive products.
Padley DJ; Dietz AB; Gastineau DA
Transfusion; 2007 Apr; 47(4):636-43. PubMed ID: 17381622
[TBL] [Abstract][Full Text] [Related]
6. Microbial contamination of BM products before and after processing: a report of incidence and immediate adverse events in 257 grafts.
Vanneaux V; Foïs E; Robin M; Rea D; de Latour RP; Biscay N; Chantre E; Robert I; Wargnier A; Traineau R; Benbunan M; Marolleau J; Socié G; Larghero J
Cytotherapy; 2007; 9(5):508-13. PubMed ID: 17786612
[TBL] [Abstract][Full Text] [Related]
7. Microbial contamination of harvested bone marrow and peripheral blood.
Prince HM; Page SR; Keating A; Saragosa RF; Vukovic NM; Imrie KR; Crump M; Stewart AK
Bone Marrow Transplant; 1995 Jan; 15(1):87-91. PubMed ID: 7742761
[TBL] [Abstract][Full Text] [Related]
8. Bacterial contamination of autologous bone marrow: reinfusion of culture-positive grafts does not result in clinical sequelae during the posttransplantation course.
Schwella N; Rick O; Heuft HG; Miksits K; Zimmermann R; Zingsem J; Eckstein R; Huhn D
Vox Sang; 1998; 74(2):88-94. PubMed ID: 9501406
[TBL] [Abstract][Full Text] [Related]
9. Microbial contamination of hematopoietic progenitor cell products: clinical outcome.
Patah PA; Parmar S; McMannis J; Sadeghi T; Karandish S; Rondon G; Tarrand J; Champlin R; de Lima M; Shpall EJ
Bone Marrow Transplant; 2007 Aug; 40(4):365-8. PubMed ID: 17572714
[TBL] [Abstract][Full Text] [Related]
10. Microbial contamination of hematopoietic progenitor cell products.
Namdaroğlu S; Tekgündüz E; Bozdağ SC; Durgun G; Sarıca A; Demiriz IŞ; Koçubaba S; Iskender G; Kayıkçı O; Altuntaş F
Transfus Apher Sci; 2013 Jun; 48(3):403-6. PubMed ID: 23664302
[TBL] [Abstract][Full Text] [Related]
11. Autologous transplant: microbial contamination of hematopoietic stem cell products.
Almeida ID; Schmalfuss T; Röhsig LM; Goldani LZ
Braz J Infect Dis; 2012; 16(4):345-50. PubMed ID: 22846122
[TBL] [Abstract][Full Text] [Related]
12. Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact.
Lowder JN; Whelton P
Cytotherapy; 2003; 5(5):377-90. PubMed ID: 14578100
[TBL] [Abstract][Full Text] [Related]
13. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections.
Del Pozo JL; Alonso M; Serrera A; Hernaez S; Aguinaga A; Leiva J
Diagn Microbiol Infect Dis; 2009 Feb; 63(2):208-12. PubMed ID: 19026506
[TBL] [Abstract][Full Text] [Related]
15. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance.
Mikulska M; Del Bono V; Raiola AM; Bruno B; Gualandi F; Occhini D; di Grazia C; Frassoni F; Bacigalupo A; Viscoli C
Biol Blood Marrow Transplant; 2009 Jan; 15(1):47-53. PubMed ID: 19135942
[TBL] [Abstract][Full Text] [Related]
16. Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients.
Gallagher JC; Perez ME; Marino EA; LoCastro LG; Abrardo LA; MacDougall C
Pharmacotherapy; 2009 Jul; 29(7):792-9. PubMed ID: 19558253
[TBL] [Abstract][Full Text] [Related]
17. A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantation.
Slavin MA; Grigg AP; Schwarer AP; Szer J; Spencer A; Sainani A; Thursky KA; Roberts AW
Bone Marrow Transplant; 2007 Jul; 40(2):157-63. PubMed ID: 17468774
[TBL] [Abstract][Full Text] [Related]
18. Microbial contamination of autologous peripheral blood stem cell products: incidence, clinical outcome, quality control and management strategies.
Cheah PL; Ong CW; Crispin P
Pathology; 2011 Jun; 43(4):340-5. PubMed ID: 21532522
[TBL] [Abstract][Full Text] [Related]
19. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of potential contaminants in blood cultures among patients in a medical center.
Lee CC; Lin WJ; Shih HI; Wu CJ; Chen PL; Lee HC; Lee NY; Chang CM; Wang LR; Ko WC
J Microbiol Immunol Infect; 2007 Oct; 40(5):438-44. PubMed ID: 17932605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]